Top

Published in:

01-11-2018 | Original Article

Validity of the central sensitization inventory with measures of sensitization in people with knee osteoarthritis

Authors: Jonathan Gervais-Hupé, Jasmine Pollice, Jackie Sadi, Lisa C. Carlesso

Published in: Clinical Rheumatology | Issue 11/2018

Abstract

Our purpose was to determine the validity of the Central Sensitization Inventory (CSI) with psychophysical tests, psychological and physical factors in patients with Knee Osteoarthritis (KOA). Patients with KOA were recruited from three Montreal hospitals. Psychophysical tests (pressure pain threshold, conditioned pain modulation, temporal summation) were conducted and questionnaires administered to determine the presence of neuropathic pain, somatization, anxiodepressive symptoms, pain catastrophizing (PC), and widespread pain (WSP). Relations between the CSI, psychophysical tests, and questionnaires were assessed using correlations and chi-square analysis. Receiver Operating Characteristics (ROC) curves determined sensitivity and specificity scores. Multiple linear regression was performed to predict the association of CSI scores with somatization, anxiodepressive symptoms, PC, and WSP factors. One hundred thirty-three participants were assessed, 56.4% female, mean age 63.5 years. The CSI was weakly correlated with decreased pressure pain thresholds locally (r_s − 0.264, p = 0.004) and remotely (r_s − 0.235, p = 0.011) and with conditioned pain modulation (r_s 0.187, p = 0.045). ROC curve analyses suggested an optimal CSI cut-point of 36 (Sn 75%, Sp 63.4%). Performance of the CSI used in combination with a neuropathic pain questionnaire was not significantly superior. After adjustment for covariates, a multivariable linear regression determined WSP (unstandardized ß 4.161(0.067, 8.255) p = 0.046), somatization (unstandardized ß 1.828 (1.368, 2.288) p < 0.005), and anxiodepressive symptoms (unstandardized ß 0.419 (0.107, 0.730) p = 0.009) significantly predicted CSI scores. The CSI is more strongly associated with psychological factors than psychophysical test results in a KOA population. Its moderate sensitivity and specificity suggest it should be used as part of a more comprehensive evaluative toolkit.

Salmon JH, Rat AC, Sellam J, Michel M, Eschard JP, Guillemin F, Jolly D, Fautrel B (2016) Economic impact of lower-limb osteoarthritis worldwide: a systematic review of cost-of-illness studies. Osteoarthr Cartil 24(9):1500–1508. https://doi.org/10.1016/j.joca.2016.03.012 CrossRef

Laslett LL, Quinn SJ, Winzenberg TM, Sanderson K, Cicuttini F, Jones G (2012) A prospective study of the impact of musculoskeletal pain and radiographic osteoarthritis on health related quality of life in community dwelling older people. BMC Musculoskelet Disord 13(1):168. https://doi.org/10.1186/1471-2474-13-168 CrossRefPubMedPubMedCentral

Neogi T (2013) The epidemiology and impact of pain in osteoarthritis. Osteoarthr Res Soc 21(9):1145–1153. https://doi.org/10.1016/j.joca.2013.03.018 CrossRef

Hawker GA, Stewart L, French MR, Cibere J, Jordan JM, March L, Suarez-Almazor M, Gooberman-Hill R (2008) Understanding the pain experience in hip and knee osteoarthritis—an OARSI/OMERACT initiative. Osteoarthr Cartil 16(4):415–422. https://doi.org/10.1016/j.joca.2007.12.017 CrossRef

Arendt-Nielsen L, Nie H, Laursen MB, Laursen BS, Madeleine P, Simonsen OH, Graven-Nielsen T (2010) Sensitization in patients with painful knee osteoarthritis. Pain 149(3):573–581. https://doi.org/10.1016/j.pain.2010.04.003 CrossRefPubMed

Latremoliere A, Woolf CJ (2010) Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J Pain 10(9):895–926. https://doi.org/10.1016/j.jpain.2009.06.012 CrossRef

Hochman JR, Gagliese L, Davis AM, Hawker GA (2011) Neuropathic pain symptoms in a community knee OA cohort. Osteoarthr Cartil 19(6):647–654. https://doi.org/10.1016/j.joca.2011.03.007 CrossRef

Felson DT (2005) The sources of pain in knee osteoarthritis. Curr Opin Rheumatol 17(5):624–628. https://doi.org/10.1097/01.bor.0000172800.49120.97 CrossRefPubMed

Woolf CJ (2011) Central sensitization: implications for the diagnosis and treatment of pain. Pain 152(SUPPL.3):S2–S15. https://doi.org/10.1016/j.pain.2010.09.030 CrossRefPubMed

10.

Neogi T, Frey-Law L, Scholz J, Niu J, Arendt-Nielsen L, Woolf C, Nevitt M, Bradley L, Felson DT, Multicenter Osteoarthritis (MOST) Study (2015) Sensitivity and sensitisation in relation to pain severity in knee osteoarthritis: trait or state? Ann Rheum Dis 74(4):682–688. https://doi.org/10.1136/annrheumdis-2013-204191 CrossRefPubMed

11.

Graven-Nielsen T, Wodehouse T, Langford RM, Arendt-Nielsen L, Kidd BL (2012) Normalization of widespread hyperesthesia and facilitated spatial summation of deep-tissue pain in knee osteoarthritis patients after knee replacement. Arthritis Rheum 64(9):2907–2916. https://doi.org/10.1002/art.34466 CrossRefPubMed

12.

Imamura M, Imamura ST, Kaziyama HHS, Targino RA, Hsing WT, De Souza LPM et al (2008) Impact of nervous system hyperalgesia on pain, disability, and quality of life in patients with knee osteoarthritis: a controlled analysis. Arthritis Rheum 59(10):1424–1431 https://doi.wiley.com/10.1002/art.24120 CrossRefPubMed

13.

Lluch E, Nijs J, Torres-Cueco R, Ló Pez Cubas C, Lluch Girbés E, Torres-Cueco R (2013) Pain treatment for patients with osteoarthritis and central sensitization. Phys Ther 93(6):842–851. https://doi.org/10.2522/ptj.20120253 CrossRef

14.

Suokas AK, Walsh DA, McWilliams DF, Condon L, Moreton B, Wylde V et al (2012) Quantitative sensory testing in painful osteoarthritis: a systematic review and meta-analysis. Osteoarthr Cartil 20(10):1075–1085. https://doi.org/10.1016/j.joca.2012.06.009 CrossRef

15.

Geber C, Klein T, Azad S, Birklein F, Gierthmühlen J, Huge V, Lauchart M, Nitzsche D, Stengel M, Valet M, Baron R, Maier C, Tölle T, Treede RD (2011) Test-retest and interobserver reliability of quantitative sensory testing according to the protocol of the German Research Network on Neuropathic Pain (DFNS): a multi-centre study. Pain 152(3):548–856. https://doi.org/10.1016/j.pain.2010.11.013 CrossRefPubMed

16.

Moreton BJ, Tew V, Das Nair R, Wheeler M, Walsh DA, Lincoln NB (2015) Pain phenotype in patients with knee osteoarthritis: classification and measurement properties of painDETECT and self-report leeds assessment of neuropathic symptoms and signs scale in a cross-sectional study. Arthritis Care Res 67(4):519–528. https://doi.org/10.1002/acr.22431 CrossRef

17.

Hochman JR, French MR, Bermingham SL, Hawker GA (2010) The nerve of osteoarthritis pain. Arthritis Care Res 62(7):1019–1023. https://doi.org/10.1002/acr.20142 CrossRef

18.

Mayer TG, Neblett R, Cohen H, Howard KJ, Choi YH, Williams MJ, Perez Y, Gatchel RJ (2012) The development and psychometric validation of the central sensitization inventory (CSI). Pain Practice 12(4):276–285. https://doi.org/10.1111/j.1533-2500.2011.00493.x CrossRefPubMed

19.

Neblett R, Hartzell MM, Cohen H, Mayer TG, Williams M, Choi Y, Gatchel RJ (2015) Ability of the central sensitization inventory to identify central sensitivity syndromes in an outpatient chronic pain sample. Clin J Pain 31(4):323–332. https://doi.org/10.1097/AJP.0000000000000113 CrossRefPubMed

20.

van Wilgen CP, Vuijk PJ, Kregel J, Voogt L, Meeus M, Descheemaeker F, Keizer D, Nijs J (2018) Psychological distress and widespread pain contribute to the variance of the central sensitization inventory: a cross-sectional study in patients with chronic pain. Pain Pract 18(2):239–246. https://doi.org/10.1111/papr.12600 CrossRefPubMed

21.

Kregel J, Schumacher C, Dolphens M, Malfliet A, Goubert D, Cagnie B et al (2018) Convergent validity of the Dutch Central Sensitization Inventory: association with psychophysical pain measures, quality of life, disability, and pain cognitions in patients with chronic spinal pain. Pain Pract 18(6):777–787. https://doi.org/10.1111/papr.12672 CrossRefPubMed

22.

Choi Y (2013) An examination of the validity of the central sensitization inventory with chronic disabling occupational musculoskeletal disorders. https://uta-ir.tdl.org/uta-ir/bitstream/handle/10106/24158/Choi_uta_2502D_12382.pdf?sequence=1&isAllowed=y. Accessed 22 May 2018

23.

Lluch Girbes E, Duenas L, Barbero M, Falla D, Baert IAC, Meeus M, Sanchez-Frutos J, Aguilella L, Nijs J (2016) Expanded distribution of pain as a sign of central sensitization in individuals with symptomatic knee osteoarthritis. Phys Ther 96(8):1196–1207. https://doi.org/10.2522/ptj.20150492 CrossRefPubMed

24.

Neogi T, Guermazi A, Roemer F, Nevitt MC, Scholz J, Arendt-Nielsen L, Woolf C, Niu J, Bradley LA, Quinn E, Frey Law L (2016) Association of joint inflammation with pain sensitization in knee osteoarthritis: the multicenter osteoarthritis study. Arthritis Rheumatol 68(3):654–661. https://doi.org/10.1002/art.39488 CrossRefPubMedPubMedCentral

25.

Kennedy DL, Kemp HI, Ridout D, Yarnitsky D, Rice ASC (2016) Reliability of conditioned pain modulation: a systematic review. Pain 157(11):2410–2419. https://doi.org/10.1097/j.pain.0000000000000689 CrossRefPubMedPubMedCentral

26.

Yarnitsky D, Bouhassira D, Drewes AM, Fillingim RB, Granot M, Hansson P, Landau R, Marchand S, Matre D, Nilsen KB, Stubhaug A, Treede RD, Wilder-Smith OHG (2015) Recommendations on practice of conditioned pain modulation (CPM) testing. Eur J Pain 19(6):805–806 https://doi.wiley.com/10.1002/ejp.605 CrossRefPubMed

27.

Scerbo T, Colasurdo J, Dunn S, Unger J, Nijs J, Cook C (2018) Measurement properties of the central sensitization inventory: a systematic review. Pain Pract 18(4):544–554. https://doi.org/10.1111/papr.12636 CrossRefPubMed

28.

Neblett R, Cohen H, Choi Y, Hartzell M, Williams M, Mayer TG et al (2013) The central sensitization inventory (csi): establishing clinically-significant values for identifying central sensitivity syndromes in an outpatient chronic pain sample. J Pain 14(5):438–445. https://doi.org/10.1016/j.jpain.2012.11.012 CrossRefPubMedPubMedCentral

29.

Cuesta-Vargas AI, Neblett R, Chiarotto A, Kregel J, Nijs J, van Wilgen CP, Pitance L, Knezevic A, Gatchel RJ, Mayer TG, Viti C, Roldan-Jiménez C, Testa M, Caumo W, Jeremic-Knezevic M, Luciano JV (2018) Dimensionality and reliability of the central sensitization inventory in a pooled multicountry sample. J Pain 19(3):317–329. https://doi.org/10.1016/j.jpain.2017.11.006 CrossRefPubMed

30.

Pitance L, Piraux E, Lannoy B, Meeus M, Berquin A, Eeckhout C, Dethier V, Robertson J, Meeus M, Roussel N (2016) Cross cultural adaptation, reliability and validity of the French version of the central sensitization inventory. Man Ther 25:e83–e84. https://doi.org/10.1016/j.math.2016.05.139 CrossRef

31.

Freynhagen R, Baron R, Gockel U, Tolle TR (2006) PainDetect: a new screening questionnaire to identity neuropathic components in patients with back pain. Curr Med Res Opin 22(10):1911–1920. https://doi.org/10.1185/030079906X132488 CrossRefPubMed

32.

Hochman JR, Davis AM, Elkayam J, Gagliese L, Hawker GA (2013) Neuropathic pain symptoms on the modified painDETECT correlate with signs of central sensitization in knee osteoarthritis. Osteoarthr Cartil 21(9):1236–1242. https://doi.org/10.1016/j.joca.2013.06.023 CrossRef

33.

Smarr KL, Keefer AL (2011) Measures of depression and depressive symptoms: Beck Depression Inventory-II (BDI-II), Center for Epidemiologic Studies Depression Scale (CES-D), Geriatric Depression Scale (GDS), Hospital Anxiety and Depression Scale (HADS), and Patient Health Questionnaire. Arthritis Care Res 63(S11):S454–S466 https://doi.wiley.com/10.1002/acr.20556 CrossRef

34.

Roberge P, Doré I, Menear M, Chartrand É, Ciampi A, Duhoux A, Fournier L (2013) A psychometric evaluation of the French Canadian version of the Hospital Anxiety and Depression Scale in a large primary care population. J Affect Disord 147(1):171–179. https://doi.org/10.1016/j.jad.2012.10.029 CrossRefPubMed

35.

Spitzer RL (1999) Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. J Am Med Assoc 282(18):1737–1744. https://doi.org/10.1001/jama.282.18.1737 CrossRef

36.

Kroenke K, Spitzer RL, Williams JBW (2002) The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms. Psychosom Med 64(2):258–266. https://doi.org/10.1097/00006842-200203000-00008 CrossRefPubMed

37.

Pfizer. Phqscreeners. https://www.phqscreeners.com/. Accessed 6 June 2018

38.

Sullivan MJL, Bishop SR, Pivik J (1995) The pain catastrophizing scale: development and validation. Psychol Assess 7(4):524–532. https://doi.org/10.1037/1040-3590.7.4.524 CrossRef

39.

Keefe FJ, Lefebvre JC, Egert JR, Affleck G, Sullivan MJ, Caldwell DS (2000) The relationship of gender to pain, pain behavior, and disability in osteoarthritis patients: the role of catastrophizing. Pain 87(3):325–334. https://doi.org/10.1016/S0304-3959(00)00296-7 CrossRefPubMed

40.

French DJ, Noël M, Vigneau F, French JA (2005) L’échelle de dramatisation face à la douleur PCS-CF: Adaptation canadienne en langue française de l’échelle « Pain Catastrophizing Scale ». Revue Canadienne des Sciences du Comportement 37(3):181–192. https://doi.org/10.1037/h0087255 CrossRef

41.

Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P, Fam AG, Farber SJ, Fiechtner JJ, Michael Franklin C, Gatter RA, Hamaty D, Lessard J, Lichtbroun AS, Masi AT, Mccain GA, John Reynolds W, Romano TJ, Jon Russell I, Sheon RP (1990) The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Arthritis Rheumatism 33(2):160–172 https://doi.wiley.com/10.1002/art.1780330203 CrossRefPubMed

42.

Carlesso LC, Segal NA, Curtis JR, Wise BL, Frey Law L, Nevitt M, Neogi T (2017) Knee pain and structural damage as risk factors for incident widespread pain: data from the multicenter osteoarthritis study. Arthritis Care Res 69(6):826–832. https://doi.org/10.1002/acr.23086 CrossRef

43.

Coronado RA, George SZ (2018) The Central Sensitization Inventory and Pain Sensitivity Questionnaire: an exploration of construct validity and associations with widespread pain sensitivity among individuals with shoulder pain. Musculoskelet Sci Pract 36:61–67. https://doi.org/10.1016/j.msksp.2018.04.009 CrossRefPubMedPubMedCentral

44.

Caumo W, Antunes LC, Elkfury JL, Herbstrith EG, Sipmann RB, Souza A et al (2017) The central sensitization inventory validated and adapted for a Brazilian population: psychometric properties and its relationship with brain-derived neurotrophic factor. J Pain Res 10:2109–2122. https://doi.org/10.2147/JPR.S131479 CrossRefPubMedPubMedCentral

Title: Validity of the central sensitization inventory with measures of sensitization in people with knee osteoarthritis
Authors: Jonathan Gervais-Hupé
Jasmine Pollice
Jackie Sadi
Lisa C. Carlesso
Publication date: 01-11-2018
Publisher: Springer London
Published in: Clinical Rheumatology / Issue 11/2018
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI: https://doi.org/10.1007/s10067-018-4279-8

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 11/2018

Chronic lung disease in U.S. Veterans with rheumatoid arthritis and the impact on survival

The relationship between bristol rheumatoid arthritis fatigue scales and disease activity of patients with rheumatoid arthritis

Management of anti-HBc-positive patients with rheumatic diseases treated with disease-modifying antirheumatic drugs—a single-center analysis of 2054 patients

Long-term effects of immunosuppressive therapy on lung function in scleroderma patients

Parathyroid hormone is a determinant of serum Dickkopf-1 levels in ankylosing spondylitis

Development of a questionnaire survey to evaluate lower limb function of patients with knee osteoarthritis

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials